Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nucleophosmin/B23 is a negative regulator of estrogen receptor α expression via AP2γ in endometrial cancer cells

Published:2016-08-04 Issue:37 Volume:7 Page:60038-60052
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lin Chiao-Yun¹²,Chao Angel¹²³,Wang Tzu-Hao¹²³,Lee Li-Yu⁴,Yang Lan-Yan⁵,Tsai Chia-Lung³,Wang Hsin-Shih¹⁶,Lai Chyong-Huey¹²

Affiliation:

1. Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, Taoyuan, Taiwan

2. Gynecologic Cancer Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan

3. Genomic Medicine Research Core Laboratory, Chang Gung Memorial Hospital, Taiwan

4. Department of Clinical Pathology, Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, Taoyuan, Taiwan

5. Statistics, Clinical Trial Center, Chang Gung Memorial Hospital, Taipei City, Taiwan

6. Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan, Taiwan

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of nucleophosmin/B23 sensitizes ovarian cancer cells to immune check-point blockade via PD-L1 in ovarian cancer;Journal of the Formosan Medical Association;2024-05

2. Roles of estrogen receptor α in endometrial carcinoma (Review);Oncology Letters;2023-10-25

3. Roles of activator protein-2 gamma in breast cancer: A narrative review (SANRA);Medicine;2022-09-23

4. The roles of estrogen receptor alpha (ERα) in endometrial carcinoma;2022-09-19

5. Exploring the Pharmacological Mechanism of the Effective Chinese Medicines Against Gynecological Cancer Based on Meta-Analysis Combined With Network Pharmacology Analysis;Frontiers in Oncology;2022-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3